orthonam

Tumor

A lump you can feel: lipoma or sarcoma?

Hee Seung Nam, MD, Orthopedic Surgeon ·

“I felt a lump in my thigh in the shower. Could it be cancer?” It is a question I hear often in clinic. Let me start with the reassuring part. Lumps you can feel are mostly benign. Only very rarely a malignant tumor called a sarcoma is mixed in, and at first a sarcoma looks almost the same as a lipoma from the outside.

What troubled me most while caring for bone and soft tissue tumor patients during residency was that the size of the later operation can change greatly depending on the order in which a lump was first investigated and treated. This article lays out how to tell lumps you need not worry about from lumps you must check.

99 of 100 lumps are benign

According to a review in the BMJ, soft tissue tumors of the limbs are about 100 times more often benign than malignant. The most common is the lipoma, a lump of fat, followed by the ganglion cyst around joints, the epidermoid cyst under the skin and the schwannoma arising from nerves.

A picture of 100 lumps as dots: 99 benign, only 1 sarcomaFor about every 100 benign lumpsthere is about one sarcomaMost are benign lumps such as lipomas, ganglion cystsand epidermoid cysts.
Figure 1. The ratio of benign to malignant soft tissue lumps shown as dots. Benign lumps, including lipomas, are overwhelmingly common.

A sarcoma is a malignant tumor that arises in connective tissue other than bone, such as muscle, fat, nerve, blood vessel and fibrous tissue. It is rare, about 1% of all adult cancers, and there are dozens of subtypes. The problem is that most are painless. Because it does not hurt, people assume “it must be a lipoma,” and often come to the hospital only after it has grown large.

How deep it lies matters

Under the skin there is a layer of fat, and beneath it the tough membrane that wraps the muscle, the fascia. Whether a lump is above or below the fascia is the first fork in the road.

Layers under the skin and the position of a lump. A shallow lump in the fat layer above the fascia and a deep lump within the muscle below the fascia12SkinSubcutaneous fatFasciaMuscleBone
Figure 2. The layers under the skin. ① A shallow lump in the subcutaneous fat above the fascia is mostly benign, such as a lipoma. ② A deep lump within or between muscles below the fascia calls for a detailed work-up regardless of size.

The ultrasound guidance of the British Sarcoma Group (BSG) explains that a fatty lump in the layer of fat just under the skin is rarely malignant even if it looks slightly unusual on ultrasound. Conversely, a lump deep below the fascia, or a lump that grew back after being removed, is more likely to be a sarcoma.

Lumps to worry about: four signs

The warning signs that UK and European sarcoma guidelines have in common are as follows. If even one applies, it is best to check with imaging.

5 cm or larger

Be careful if it is bigger than a golf ball (about 4.3 cm). A typical lipoma in the subcutaneous fat may be an exception.

Deep, below the fascia

A lump within or between muscles needs to be checked regardless of size.

Gradually getting bigger

If you can feel it growing over weeks or months, it is the most important sign.

Painful, or came back after removal

A lump that has become painful, or that came back in the same spot after surgery, also needs to be checked.

The UK National Institute for Health and Care Excellence (NICE) recommends that adults with a growing lump of unknown cause have an ultrasound within two weeks. The European Society for Medical Oncology (ESMO) guideline also recommends that a superficial lump larger than 5 cm, or a deep lump, be checked with imaging and biopsy.

There are liposarcomas that look like lipomas

Not every lump made of fat is a lipoma. Among fatty tumors that grow large in deep places, such as between thigh muscles, some are atypical lipomatous tumors (well-differentiated liposarcoma). They almost never spread elsewhere, but if removed incompletely they grow back and, rarely, can change into a more aggressive form.

In a study by a German team that compared 113 fatty tumors with MRI and genetic testing, there was not a single atypical lipomatous tumor in the fat layer under the skin, and most lay between muscles. On MRI, septa thicker than 2 mm, areas that brighten with contrast and very large size were the suspicious findings, and the final confirmation is made by finding MDM2 gene amplification in tissue.

Common lipomaAtypical lipomatous tumor, liposarcoma
LocationOften in the fat layer under the skinBetween muscles, deep below the fascia
SizeUsually under 5 cmMay grow to 10 cm or more
MRIUniform fat, thin septaThick septa, nodules, contrast enhancement
TreatmentSimple removal if bothersomeA planned operation, with follow-up needed

There is an order to the tests

The order of tests when a lump is found. After examination and ultrasound, a typical shallow lipoma is observed or removed; if there are warning signs, MRI and needle biopsy come before surgeryA lump is foundExamination and ultrasoundCheck size, depth and appearanceA shallow, small, typical lipomaPainless and not growingAny one warning signor the ultrasound finding is unclearObservationor simple removalMRIDefine the extent and nature of the tumorNeedle biopsyThe surgical team plans the siteSurgery and treatment matched to the diagnosis
Figure 3. The order of tests when a lump is found. If there are warning signs, MRI and biopsy come before surgery.
  • Ultrasound: the first test. It shows the depth and size of the lump, its internal appearance and blood flow. A typical shallow lipoma or ganglion cyst can mostly be judged on ultrasound alone.
  • MRI: if there are warning signs or the ultrasound finding is unclear, MRI is used to check the extent and nature of the tumor and its relation to nearby nerves and vessels.
  • Biopsy: a bit of tissue is taken with a thick needle to confirm the diagnosis. Because the biopsy tract must also be removed with the tumor later, the principle is that the team that will do the final surgery plans where the needle goes in.

In a study by the Musculoskeletal Tumor Society in the United States that analyzed 597 patients, when the biopsy was done somewhere other than a tumor treatment center, diagnostic errors and complications were 2 to 12 times more frequent. In 19% of all patients, treatment became more complicated because of biopsy problems, and there were 18 amputations that could have been avoided.

Why “let's just take it out first” is dangerous

Sometimes a small, soft lump is removed without imaging and the biopsy then shows a sarcoma. In a meta-analysis (2024) of such unplanned excisions, when a wide re-excision was done, about 60% still had tumor remaining, and the five-year local recurrence risk was higher than with planned surgery.

To be fair, in this study there was no meaningful difference in overall survival. But to get rid of the remaining tumor you have to operate again much more widely than the first time, and radiation treatment is added in some cases. If sarcoma had been kept in mind and planned for from the start, it could have been done in one operation. That is why the principle is to get imaging first, before removing a lump that has warning signs.

In closing

  • Lumps you need not worry too much about: a lump just under the skin that is small and soft, has stayed the same size for years and does not hurt is mostly a lipoma. Even so, have it checked once with an examination and ultrasound.
  • Lumps you must check: 5 cm or larger, deep below the fascia, getting bigger, painful or recurrent. If even one of these applies, check with ultrasound and MRI, and if needed have a biopsy by a team experienced in tumor treatment.
  • The order matters: imaging, then biopsy, then surgery. Following this order alone can change the outcome of sarcoma treatment.

This article is general medical information. The tests and treatment needed can differ with the location and size of the lump and the imaging findings, so please confirm through an examination.

References

  1. Mannan K, Briggs TW. Soft tissue tumours of the extremities. BMJ. 2005;331(7517):590.
  2. Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J, Judson I. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016;6:20.
  3. British Sarcoma Group. Ultrasound screening of soft tissue masses in the trunk and extremity: a BSG guide for ultrasonographers and primary care.
  4. Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(11):1348–1365.
  5. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral (NG12).
  6. Knebel C, Neumann J, Schwaiger BJ, et al. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status. BMC Cancer. 2019;19.
  7. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. J Bone Joint Surg Am. 1996;78(5):656–663.
  8. Larios F, Gonzalez MR, Ruiz-Arellanos K, Silva GAE, Pretell-Mazzini J. Is unplanned excision of soft tissue sarcomas associated with worse oncological outcomes? A systematic review and meta-analysis. Cancers. 2024;16(2):443.